The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation
Open Access
- 28 August 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 14 (9), 1287-1293
- https://doi.org/10.1002/lt.21524
Abstract
Although hyperinsulinemia and its associated metabolic syndrome (MS) have been implicated in the progression of hepatic fibrosis in hepatitis C virus (HCV) patients, little is known about the consequences of MS after orthotopic liver transplantation (OLT). The aim of this study was to assess the association between MS and fibrosis progression in patients with recurrent HCV after OLT. We identified all OLT/HCV patients (1998-2005) with at least 2 post-OLT liver biopsies. MS was defined with Adult Treatment Panel III criteria at 1 year post-OLT. The Ludwig-Batts scoring system was used to stage all biopsies (408 biopsies from 95 patients). The first biopsy that showed progression post-OLT was used for the time-to-progression analysis. Univariable and multivariable logistic regression analysis was performed to identify factors associated with fibrosis progression. MS was present in 50% of patients. Average follow-up to last available biopsy was 24 ± 17 months, during which 72% of subjects had fibrosis progression. The overall median rate of fibrosis progression was 0.08 units per month (Q25, Q75: 0.0, 0.17). By univariable analysis, high HCV RNA at 4 months post-OLT (P < 0.001), diabetes (P = 0.046), cytomegalovirus infection (P = 0.006), and MS (P = 0.049) were associated with progression of fibrosis. In multivariable analysis, MS was independently associated with progression of fibrosis beyond 1 year after OLT (odds ratio = 6.3, P = 0.017). A high viral load at 4 months post-OLT (odds ratio = 1.1, P = 0.004) and steroid therapy for acute rejection (odds ratio = 1.9, P = 0.05) were independently associated with fibrosis progression. In conclusion, MS, a potentially modifiable disease, is common and is strongly associated with long-term fibrosis progression in the setting of recurrent HCV after OLT. Liver Transpl 14:1287–1293, 2008. © 2008 AASLD.Keywords
This publication has 26 references indexed in Scilit:
- The Impact of Diabetes Mellitus on Fibrosis Progression in Patients Transplanted for Hepatitis CAmerican Journal of Transplantation, 2006
- Prevalence and Risk Factors for Diabetes Mellitus in Moderate Term Survivors of Liver TransplantationAmerican Journal of Transplantation, 2006
- Insulin Resistance Plays a Significant Role in Liver Fibrosis in Chronic Hepatitis C and in the Response to Antiviral TherapyThe American Journal of Gastroenterology, 2005
- Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistanceGastroenterology, 2004
- Steatosis and hepatitis C virus: Mechanisms and significance for hepatic and extrahepatic diseaseGastroenterology, 2004
- Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcoholHepatology, 2002
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosisHepatology, 1999
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996